发明名称 INDOLINE OR TETRAHYDROQUINOLINE DERIVATIVES
摘要 Indoline or tetrahydroquinoline derivatives represented by general formula (I) or pharmacologically acceptable salts thereof, which exhibit an excellent inhibitory activity against activated blood coagulation factor X and are useful as therapeutic or preventive drugs for blood coagulation diseases wherein R<1> is hydrogen, optionally substituted alkyl, optionally substituted alkanoyl, optionally substituted alkylsulfonyl, optionally substituted arylsulfonyl, or optionally substituted sulfamoyl; R<2> is optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted amino, or optionally substituted saturated cyclic amino; R<3> and R<4> are each hydrogen, halogeno, alkyl, alkoxy, cyano, nitro, hydroxyl, or alkanoyloxy; A is a single bond, alkylene, oxygen, or -O(CH2)m- (wherein m is 1 to 4); and n is 1 or 2.
申请公布号 WO0102356(A1) 申请公布日期 2001.01.11
申请号 WO2000JP04333 申请日期 2000.06.30
申请人 SANKYO COMPANY, LIMITED;FUJIMOTO, KOICHI;ASAI, FUMITOSHI;TANAKA, NAOKI;MATSUHASHI, HAYAO;SUGIDACHI, ATSUHIRO;TANIMOTO, TATSUO 发明人 FUJIMOTO, KOICHI;ASAI, FUMITOSHI;TANAKA, NAOKI;MATSUHASHI, HAYAO;SUGIDACHI, ATSUHIRO;TANIMOTO, TATSUO
分类号 A61P7/02;A61P9/10;C07D231/56;C07D401/04;C07D401/06;C07D401/12;C07D401/14;C07D403/04;C07D403/12;C07D403/14;C07D405/06;C07D405/14;C07D409/06;C07D409/12;C07D409/14;C07D413/12;C07D417/12;C07D417/14;C07D471/04;(IPC1-7):C07D209/14;C07D215/20;C07D215/58;A61K31/404;A61K31/443;A61K31/454;A61K31/47;A61K31/470;A61K31/496;A61K31/537 主分类号 A61P7/02
代理机构 代理人
主权项
地址